Biden’s parting gift to Big Pharma will hammer GLP-1 patients — like me
This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...
Healio1d
Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
Endpoints News5d
Com­pounders’ mo­tion for pre­lim­i­nary in­junc­tion de­nied in case over tirzepatide short­age
Compounding pharmacies faced a major setback in their case over the FDA’s decision to remove the obesity drug tirzepatide ...
Fierce Pharma8d
Texas court decision prevents compounders from producing knockoffs of Eli Lilly's tirzepatide
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...